PSORIASIS GUTTATE

Clinical trials for PSORIASIS GUTTATE explained in plain language.

Never miss a new study

Get alerted when new PSORIASIS GUTTATE trials appear

Sign up with your email to follow new studies for PSORIASIS GUTTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for psoriasis: Immune-Targeting drug under study

Disease control Ongoing

This study looks at how the drug guselkumab affects the immune system in people with plaque or guttate psoriasis. About 25 adults with recent-onset guttate or plaque psoriasis will receive treatment. The goal is to understand changes in immune cells that cause psoriasis symptoms.

Matched conditions: PSORIASIS GUTTATE

Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control

Last updated May 07, 2026 18:41 UTC

PSORIASIS GUTTATE

Get alerted when new PSORIASIS GUTTATE trials appear

New hope for psoriasis: Immune-Targeting drug under study